• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIO-RAD MEDICAL DIAGNOSTICS GMBH TANGO INFINITY; AUTOMATED BLOOD BANK ANALYSER SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIO-RAD MEDICAL DIAGNOSTICS GMBH TANGO INFINITY; AUTOMATED BLOOD BANK ANALYSER SYSTEM Back to Search Results
Model Number 850000010
Device Problems False Negative Result (1225); Component Missing (2306); Defective Device (2588)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/17/2019
Event Type  malfunction  
Manufacturer Narrative
This is our initial report on this incident.
 
Event Description
The customer reported false negative or weak antibody screening and identification results for several samples when compared with results generated with tube testing using the enhancement medium polyethylene glycol (peg) and the competitor instrument echo.In particular the customer reported a missed antibody when using biotestcell 3 lot #8850011-00 on two different tango infinity instruments.The customer stated that the specificity of the missed antibody was anti-jk(a).The customer did not return the patient sample that had caused a false negative test result but did sent in the complaint sample of biotestcell 3 and further reagents.Within its shelf life the retention sample of the supposedly defective lot of biotestcell 3 was tested by our quality control laboratory with different controls and samples, e.G.Anti-jk(a) on tango infinity.All positive and negative reactions were correct.We did not observe any false negative reaction.Testing of the reagents provided by customer is still ongoing.A review of the batch record documentation showed no irregularities which might have negatively affected the quality of the allegedly defective lot.Regarding the affected tango infinity, the result images of sample in question were reviewed and the negative reactions could be confirmed also visually.The instrument was inspected by our field service engineer on january 23, 2019.He performed minor adjustments as well as coordinated teaching.Upon metrology, serology and titration testing, the instrument was confirmed to operate within specification.The metrology qualification procedure was completed on 01/23/2019 with passing results.Dilution studies were performed using the solidscreen ii qc positive control.The results were as expected.In some cases there was a "?" interpreted result for a strong positive reaction.This phenomenon is known and can be addressed by installing the sp4 upgrade.The customer then tested the sample on manual tube with both liss and peg.Tested with 2 jka homozygous cells from immuco pano-cell lot 48411, exp 2/1/2019 (cells 4 and 5).Cells 4 and 5 were negative in tube testing with liss.Cell 4 was negative and cell 5 was +/- in tube testing with peg.Both tango infinity instruments gave negative results.The log files did not show any issue relevant abnormalities.No indication for an instrument malfunction could be identified.The service engineer confirmed a proper function of the instrument by metrology qualification.As to the database, no problems with quality control testing on solidscreen ii method occurred.Since the samples were not available, we can only speculate that the antibodies were present in too low concentration and are borderline to be detected by the solidscreen ii method.Also, customer uses different methods, which are not comparable, such as the tube technique with peg enhancement.The instruction for use contains the following statement: negative reactions can occur in samples with excessively low antibody concentration because this test method cannot detect them.No test method can detect all blood group antibodies.
 
Event Description
The customer reported false negative or weak antibody screening and identification results for several samples when compared with results generated with tube testing using the enhancement medium polyethylen glycol (peg) and the competitor instrument echo.In particular the customer reported a missed antibody when using biotestcell 3 lot #8850011-00 on two different tango infinity instruments.The customer stated that the specificity of the missed antibody was anti-jk(a).During the course of the complaint handling the customer informed us about the false negative reaction of the anti-jk(a) with biotestcell-i11 plus (ref # 816022100, lot #8850011-00, expiry date 2019-02-04.At the time the customer informed us, the supposedly defective lot of biotestcell-i11 plus was already expired.Therefore our quality control laboratory did not test their retention sample.The customer did not return the patient sample that had caused a false negative test result but the complaint sample, two different lots of anti-human globulin (ahg) anti-igg solidscreen ii and mlb2.At the time our quality control laboratory received the reagents provided by the customer, the supposedly defective lot of biotestcell 3 was already expired.But the retention sample of the allegedly defective lot of biotestcell 3 was tested in our qc laboratory within its shelf life with different controls and samples, e.G.An anti-jk(a) on tango infinity.All positive and negative reactions were correct.We did not observe any false negative reaction.Furthermore both ahg reagents provided by the customer were tested for potency and specificity and met the acceptance criteria.The mlb2 was also tested and met the acceptance criteria.Testing by our quality control laboratory confirmed that the allegedly defective lot of biotestcell 3 functions correctly.A review of the batch record documentation showed no irregularities which might have negatively affected the quality of the allegedly defective lot.Regarding the affected tango infinity, the result images of sample in question were reviewed and the negative reactions could be confirmed also visually.The instrument was inspected by our field service engineer on january 23, 2019.He performed minor adjustments as well as coordinated teaching.Upon metrology, serology and titration testing, the instrument was confirmed to operate within specification.The metrology qualification procedure was completed on 01/23/2019 with passing results.Dilution studies were performed using the solidscreen ii qc positive control.The results were as expected.In some cases there was a "?" interpreted result for a strong positive reaction.This phenomenon is known and can be addressed by installing the sp4 upgrade.The customer then tested the sample on manual tube with both liss and peg.Tested with 2 jka homozygous cells from immuco pano-cell lot 48411 exp 2/1/19 (cells 4 and 5).Cells 4 and 5 were negative in tube testing with liss.Cell 4 was negative and cell 5 was +/- in tube testing with peg.Both tango infinity instruments gave negative results.The log files did not show any issue relevant abnormalities.No indication for an instrument malfunction could be identified.The service engineer confirmed a proper function of the instrument by metrology qualification.As to the database, no problems with quality control testing on solidscreen ii method occurred.Since the samples were not available, we can only speculate that the antibodies were present in too low concentration and are boarderline to be detected by the solidscreen ii method.Also, customer uses different methods, which are not comparable, such as the tube technique with peg enhancement.The instruction for use contains the following statement: negative reactions can occur in samples with excessively low antibody concentration because this test method cannot detect them.No test method can detect all blood group antibodies.
 
Manufacturer Narrative
This is our final report on this incident.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TANGO INFINITY
Type of Device
AUTOMATED BLOOD BANK ANALYSER SYSTEM
Manufacturer (Section D)
BIO-RAD MEDICAL DIAGNOSTICS GMBH
industriestrasse 1
dreieich, hessen 63303
GM  63303
MDR Report Key8338640
MDR Text Key139989364
Report Number9610824-2019-00003
Device Sequence Number1
Product Code KSZ
UDI-Device Identifier07611969961719
UDI-Public(01)07611969961719
Combination Product (y/n)N
PMA/PMN Number
BK150327
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 03/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number850000010
Device Catalogue Number850000010
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 01/18/2019
Initial Date FDA Received02/14/2019
Supplement Dates Manufacturer Received01/18/2019
Supplement Dates FDA Received03/11/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AHG ANTI-IGG SOLIDSCREEN II.; BIOTESTCELL 11 PLUS, LOT UNKNOWN.; BIOTESTCELL 11 PLUS, LOT UNKNOWN.; BIOTESTCELL 3, LOT # 8850011-00, EXP. 02/04/2019.; BIOTESTCELL 3, LOT # 8850011-00, EXP. 02/04/2019.; MLB2.
-
-